Perinatal inflammation influences but does not arrest rapid immune development in preterm babies

S Kamdar1, R Hutchinson2,3, A Laing1

  • 1Peter Gorer Department of Immunobiology, King's College London, London, SE1 9RT, UK.

Nature Communications
|March 11, 2020
PubMed

Insights

Preterm infants can develop adult-like immune function rapidly, independent of their microbiome. However, infections in preterm babies show distinct immune cell differences that may predict clinical outcomes.

Area of Science:

  • Neonatal immunology
  • Preterm infant health
  • Infectious disease complications

Background:

  • Preterm birth (<32 weeks gestation) poses significant risks for infection and related mortality.
  • Understanding immune system development and its modulation by perinatal factors in preterm infants is limited.

Purpose of the Study:

  • To prospectively and longitudinally investigate immune system development in preterm infants.
  • To identify how perinatal factors, including infection, influence immune maturation.
  • To explore potential predictors of infection-related outcomes in this population.

Main Methods:

  • Longitudinal cohort study of infants born before 32 weeks gestation.
  • Assessment of immune cell functionality, including T cell responses (CXCL8, TNF).
  • Analysis of immune maturation in relation to microbiome development and infection history.

Main Results:

  • Preterm infants demonstrate rapid acquisition of adult-level immune functionality, irrespective of microbiome diversity.
  • Infants exposed to in utero or postnatal infection showed reduced CXCL8-producing T cells but comparable TNF-producing T cells.
  • These immune differences preceded an unstable postnatal clinical course.

Conclusions:

  • Rapid immune maturation is achievable in preterm infants.
  • Specific T cell functional differences can be identified following infection exposure.
  • These immune markers may serve as predictors for subsequent infection-mediated outcomes in preterm infants.